Aeovian Pharmaceuticals
Berkeley, California, United States · Biopharma, Biotechnology, Healthcare · 9 employees
Aeovian Pharmaceuticals is a clinical-stage biopharmaceutical company developing targeted and highly selective small molecules to restore cellular metabolic quality control, thereby addressing the dysregulated growth and hyperactive signaling found in certain rare genetic and age-related diseases.
Funding history
- Funding Round — $55.0M — Dec 2025
- Series SERIES B — $55.0M — Dec 2025
- Funding Round — $50.4M — May 2024
- Funding Round — $18.8M — Oct 2019
Recent signals
- Dec 22, 2025: Raised $55.0M
- Dec 16, 2025: Raised $55.0M in Series SERIES B
- May 13, 2024: Raised $50.4M
- Oct 09, 2019: Raised $18.8M
See plans & pricing → Track Aeovian Pharmaceuticals’s funding, hiring, and signals — with verified contacts — on Fundz.